China · Delayed Price · Currency is CNY Tibet Weixinkang Medicine Statistics
Total Valuation
SHA:603676 has a market cap or net worth of CNY 3.97 billion. The enterprise value is 2.92 billion.
| Market Cap | 3.97B |
| Enterprise Value | 2.92B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
SHA:603676 has 432.33 million shares outstanding. The number of shares has decreased by -0.98% in one year.
| Current Share Class | 432.33M |
| Shares Outstanding | 432.33M |
| Shares Change (YoY) | -0.98% |
| Shares Change (QoQ) | +2.81% |
| Owned by Insiders (%) | 22.57% |
| Owned by Institutions (%) | 2.36% |
| Float | 95.77M |
Valuation Ratios
The trailing PE ratio is 20.46.
| PE Ratio | 20.46 |
| Forward PE | n/a |
| PS Ratio | 3.50 |
| PB Ratio | 2.58 |
| P/TBV Ratio | 2.61 |
| P/FCF Ratio | 25.23 |
| P/OCF Ratio | 16.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.48, with an EV/FCF ratio of 18.53.
| EV / Earnings | 15.10 |
| EV / Sales | 2.57 |
| EV / EBITDA | 10.48 |
| EV / EBIT | 12.86 |
| EV / FCF | 18.53 |
Financial Position
The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.62 |
| Quick Ratio | 3.18 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.07 |
| Interest Coverage | 1,592.26 |
Financial Efficiency
Return on equity (ROE) is 12.74% and return on invested capital (ROIC) is 36.32%.
| Return on Equity (ROE) | 12.74% |
| Return on Assets (ROA) | 7.37% |
| Return on Invested Capital (ROIC) | 36.32% |
| Return on Capital Employed (ROCE) | 14.34% |
| Weighted Average Cost of Capital (WACC) | 3.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 763 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 8.19 |
Taxes
In the past 12 months, SHA:603676 has paid 50.32 million in taxes.
| Income Tax | 50.32M |
| Effective Tax Rate | 20.68% |
Stock Price Statistics
The stock price has decreased by -28.50% in the last 52 weeks. The beta is -0.08, so SHA:603676's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | -28.50% |
| 50-Day Moving Average | 9.02 |
| 200-Day Moving Average | 10.12 |
| Relative Strength Index (RSI) | 50.81 |
| Average Volume (20 Days) | 2,255,387 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603676 had revenue of CNY 1.13 billion and earned 193.00 million in profits. Earnings per share was 0.45.
| Revenue | 1.13B |
| Gross Profit | 678.33M |
| Operating Income | 226.76M |
| Pretax Income | 243.32M |
| Net Income | 193.00M |
| EBITDA | 271.68M |
| EBIT | 226.76M |
| Earnings Per Share (EPS) | 0.45 |
Balance Sheet
The company has 1.06 billion in cash and 11.05 million in debt, with a net cash position of 1.05 billion or 2.44 per share.
| Cash & Cash Equivalents | 1.06B |
| Total Debt | 11.05M |
| Net Cash | 1.05B |
| Net Cash Per Share | 2.44 |
| Equity (Book Value) | 1.54B |
| Book Value Per Share | 3.51 |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was 243.82 million and capital expenditures -86.49 million, giving a free cash flow of 157.33 million.
| Operating Cash Flow | 243.82M |
| Capital Expenditures | -86.49M |
| Depreciation & Amortization | 44.92M |
| Net Borrowing | -2.01M |
| Free Cash Flow | 157.33M |
| FCF Per Share | 0.36 |
Margins
Gross margin is 59.82%, with operating and profit margins of 20.00% and 17.02%.
| Gross Margin | 59.82% |
| Operating Margin | 20.00% |
| Pretax Margin | 21.46% |
| Profit Margin | 17.02% |
| EBITDA Margin | 23.96% |
| EBIT Margin | 20.00% |
| FCF Margin | 13.88% |
Dividends & Yields
This stock pays an annual dividend of 0.33, which amounts to a dividend yield of 3.59%.
| Dividend Per Share | 0.33 |
| Dividend Yield | 3.59% |
| Dividend Growth (YoY) | -4.39% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 76.29% |
| Buyback Yield | 0.98% |
| Shareholder Yield | 4.56% |
| Earnings Yield | 4.86% |
| FCF Yield | 3.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |